-
1
-
-
9644252909
-
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
-
DOI 10.1001/jama.292.21.2585
-
Graham, D.J. et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292, 2585-2590 (2004). (Pubitemid 39577514)
-
(2004)
Journal of the American Medical Association
, vol.292
, Issue.21
, pp. 2585-2590
-
-
Graham, D.J.1
Staffa, J.A.2
Shatin, D.3
Andrade, S.E.4
Schech, S.D.5
La Grenade, L.6
Gurwitz, J.H.7
Chan, K.A.8
Goodman, M.J.9
Platt, R.10
-
2
-
-
74249112988
-
Prevalence of osteonecrosis of the jaw in patients witHoral bisphosphonate exposure
-
Predicting Risk of Osteonecrosis of the Jaw witHoral Bisphosphonate Exposure (PROBE) Investigators
-
Lo, J.C. et al.; Predicting Risk of Osteonecrosis of the Jaw witHoral Bisphosphonate Exposure (PROBE) Investigators. Prevalence of osteonecrosis of the jaw in patients witHoral bisphosphonate exposure. J. Oral Maxillofac. Surg. 68, 243-253 (2010).
-
(2010)
J. Oral Maxillofac. Surg.
, vol.68
, pp. 243-253
-
-
Lo, J.C.1
-
3
-
-
77954988618
-
Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone
-
Graham, D.J. et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA 304, 411-418 (2010).
-
(2010)
JAMA
, vol.304
, pp. 411-418
-
-
Graham, D.J.1
-
4
-
-
84857237181
-
Neuropsychiatric events in varenicline compared to nicotine replacement therapy (NRT) patch users, Military Health System (MHS)
-
Meyer, T.E. et al. Neuropsychiatric events in varenicline compared to nicotine replacement therapy (NRT) patch users, Military Health System (MHS). Pharmacoepidemiol Drug Saf. 20, S245-S246 (2011).
-
(2011)
Pharmacoepidemiol Drug Saf.
, vol.20
-
-
Meyer, T.E.1
-
5
-
-
3042623891
-
Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy
-
DOI 10.1002/pds.977
-
Chang, J.T., Staffa, J.A., Parks, M. & Green, L. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Pharmacoepidemiol. Drug Saf. 13, 417-426 (2004). (Pubitemid 38996852)
-
(2004)
Pharmacoepidemiology and Drug Safety
, vol.13
, Issue.7
, pp. 417-426
-
-
Chang, J.T.1
Staffa, J.A.2
Parks, M.3
Green, L.4
-
6
-
-
34548827696
-
The concomitant prescribing of ethinyl estradiol/drospirenone and potentially interacting drugs
-
DOI 10.1016/j.contraception.2007.06.002, PII S0010782407003149
-
McAdams, M., Staffa, J.A. & Dal Pan, G.J. The concomitant prescribing of ethinyl estradiol/drospirenone and potentially interacting drugs. Contraception 76, 278-281 (2007). (Pubitemid 47444286)
-
(2007)
Contraception
, vol.76
, Issue.4
, pp. 278-281
-
-
McAdams, M.1
Staffa, J.A.2
Dal Pan, G.J.3
-
7
-
-
0034694849
-
Contraindicated use cisapride: Impact of Food and Drug Administration regulatory action
-
Smalley, W. et al. Contraindicated use of cisapride: impact of food and drug administration regulatory action. JAMA 284, 3036-3039 (2000). (Pubitemid 32014741)
-
(2000)
Journal of the American Medical Association
, vol.284
, Issue.23
, pp. 3036-3039
-
-
Smalley, W.1
Shatin, D.2
Wysowski, D.K.3
Gurwitz, J.4
Andrade, S.E.5
Goodman, M.6
Chan, K.A.7
Platt, R.8
Schech, S.D.9
Ray, W.A.10
-
8
-
-
13844320866
-
Tardive dyskinesia risks and metoclopramide use before and after U.S market withdrawal of cisapride
-
Shaffer, D., Butterfield, M., Pamer, C. & Mackey, A.C. Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride. J. Am. Pharm. Assoc. (2003). 44, 661-665 (2004).
-
(2003)
J. Am. Pharm. Assoc.
, vol.44
, pp. 661-665
-
-
Shaffer, D.1
Butterfield, M.2
Pamer, C.3
MacKey, A.C.4
-
9
-
-
34548276415
-
Duration of therapy with metoclopramide: A prescription claims data study
-
DOI 10.1002/pds.1397
-
Kaplan, S., Staffa, J.A. & Dal Pan, G.J. Duration of therapy with metoclopramide: a prescription claims data study. Pharmacoepidemiol. Drug Saf. 16, 878-881 (2007). (Pubitemid 47322587)
-
(2007)
Pharmacoepidemiology and Drug Safety
, vol.16
, Issue.8
, pp. 878-881
-
-
Kaplan, S.1
Staffa, J.A.2
Dal Pan, G.J.3
-
10
-
-
76149135710
-
Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions
-
Pamer, C.A. et al. Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions. Pharmacoepidemiol. Drug Saf. 19, 158-174 (2010).
-
(2010)
Pharmacoepidemiol. Drug Saf.
, vol.19
, pp. 158-174
-
-
Pamer, C.A.1
-
11
-
-
80051509793
-
Changes in topical calcineurin use following regulatory actions in the U.S
-
Moeny, D., La Grenade, L. & Brinker, A. Changes in topical calcineurin use following regulatory actions in the U.S. Pharmacoepidemiol. Drug Saf. 18 (suppl. 1), S180 (2009).
-
(2009)
Pharmacoepidemiol. Drug Saf.
, vol.18
, Issue.SUPPL. 1
-
-
Moeny, D.1
La Grenade, L.2
Brinker, A.3
-
12
-
-
33750106228
-
National surveillance of emergency department visits for outpatient adverse drug events
-
Budnitz, D.S., Pollock, D.A., Weidenbach, K.N., Mendelsohn, A.B., Schroeder, T.J. & Annest, J.L. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296, 1858-1866 (2006). (Pubitemid 44596195)
-
(2006)
Journal of the American Medical Association
, vol.296
, Issue.15
, pp. 1858-1866
-
-
Budnitz, D.S.1
Pollock, D.A.2
Weidenbach, K.N.3
Mendelsohn, A.B.4
Schroeder, T.J.5
Annest, J.L.6
-
13
-
-
0037116642
-
Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey
-
Kaufman, D.W., Kelly, J.P., Rosenberg, L., Anderson, T.E. & Mitchell, A.A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287, 337-344 (2002). (Pubitemid 34251967)
-
(2002)
Journal of the American Medical Association
, vol.287
, Issue.3
, pp. 337-344
-
-
Kaufman, D.W.1
Kelly, J.P.2
Rosenberg, L.3
Anderson, T.E.4
Mitchell, A.A.5
-
14
-
-
65249098556
-
Emergency department visits attributed to selected analgesics United States 2004-2005
-
Willy, M., Kelly, J.P., Nourjah, P., Kaufman, D.W., Budnitz, D.S. & Staffa, J. Emergency department visits attributed to selected analgesics, United States, 2004-2005. Pharmacoepidemiol. Drug Saf. 18, 188-195 (2009).
-
(2009)
Pharmacoepidemiol. Drug Saf.
, vol.18
, pp. 188-195
-
-
Willy, M.1
Kelly, J.P.2
Nourjah, P.3
Kaufman, D.W.4
Budnitz, D.S.5
Staffa, J.6
-
15
-
-
79851472033
-
Developing the Sentinel System-a national resource for evidence development
-
Behrman, R.E., Benner, J.S., Brown, J.S., McClellan, M., Woodcock, J. & Platt, R. Developing the Sentinel System-a national resource for evidence development. N. Engl. J. Med. 364, 498-499 (2011).
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 498-499
-
-
Behrman, R.E.1
Benner, J.S.2
Brown, J.S.3
McClellan, M.4
Woodcock, J.5
Platt, R.6
-
16
-
-
78751688048
-
Advancing the science for active surveillance: Rationale and design for the Observational Medical Outcomes Partnership
-
Stang, P.E. et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann. Intern. Med. 153, 600-606 (2010).
-
(2010)
Ann. Intern. Med.
, vol.153
, pp. 600-606
-
-
Stang, P.E.1
-
17
-
-
40949139727
-
Estimating the extent of reporting to FDA: A case study of statin-associated rhabdomyolysis
-
DOI 10.1002/pds.1535
-
McAdams, M., Staffa, J. & Dal Pan, G. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis. Pharmacoepidemiol. Drug Saf. 17, 229-239 (2008). (Pubitemid 351404034)
-
(2008)
Pharmacoepidemiology and Drug Safety
, vol.17
, Issue.3
, pp. 229-239
-
-
MacAdams, M.1
Staffa, J.2
Dal Pan, G.3
-
18
-
-
0002656565
-
Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs
-
Rainsford K.D. & Velo G.P. (eds). Raven Press: New York
-
Weber, J.C.P. Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs. In Advances in Inflammation Research, Rainsford K.D. & Velo G.P. (eds). Raven Press: New York, 1984:1-7.
-
(1984)
Advances in Inflammation Research
, pp. 1-7
-
-
Weber, J.C.P.1
-
19
-
-
52949152357
-
Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: Revisiting the Weber effect. Pharmacoepidemiol
-
McAdams, M.A., Governale, L.A., Swartz, L., Hammad, T.A. & Dal Pan, G.J. Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: revisiting the Weber effect. Pharmacoepidemiol. Drug Saf. 17, 882-889 (2008).
-
(2008)
Drug Saf.
, vol.17
, pp. 882-889
-
-
McAdams, M.A.1
Governale, L.A.2
Swartz, L.3
Hammad, T.A.4
Dal Pan, G.J.5
-
21
-
-
80054802888
-
Secondary use of randomized controlled trials to evaluate drug safety: A review of methodological considerations
-
Hammad, T.A., Pinheiro, S.P. & Neyarapally, G.A. Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations. Clin. Trials 8, 559-570 (2011).
-
(2011)
Clin. Trials
, vol.8
, pp. 559-570
-
-
Hammad, T.A.1
Pinheiro, S.P.2
Neyarapally, G.A.3
|